Patrick Hagen, MD, named director of Hematology, Bone Marrow Transplant & Cellular Therapy
November 14, 2025
CONTACT:
Allison Peters
allison.peters@luhs.org
708-216-6140
MAYWOOD, IL – Patrick Hagen, MD, has been appointed Director of Hematology, Bone Marrow Transplant (BMT) & Cellular Therapy at Loyola Medicine.
Dr. Hagen is a board-certified malignant hematologist and stem cell transplant physician who has been part of Loyola Medicine since 2017. He performs autologous and allogeneic stem cell transplants and CAR-T therapy, with a clinical focus on leukemia, lymphoma, multiple myeloma and systemic light chain amyloidosis—areas in which he leads innovative research and clinical trials.
An associate professor in the Division of Hematology/Oncology at Loyola University Chicago Stritch School of Medicine, Dr. Hagen completed his internal medicine residency at the University of Minnesota and his fellowship in hematology and bone marrow transplantation at Loyola.
Clinical leader in hematology and bone marrow transplants
Over the years, Dr. Hagen has held key leadership roles, including director of BMT quality improvement, associate director of the cancer clinical trials office, and most recently, interim director of the program for the past two and a half years. He trained under Patrick Stiff, MD, who led the program for nearly four decades, and brings deep institutional knowledge and a strong commitment to continuing its legacy of excellence.
Compassionate patient advocate for stem cell transplant recipients
Beyond his clinical and academic contributions, Dr. Hagen is a passionate advocate for patients. He leads Loyola’s annual Bone Marrow Transplant Celebration of Survivorship, now in its 33rd year—a cherished event that honors transplant recipients, donors, families and care teams.
“Dr. Hagen’s dedication to patient care, mentorship and excellence in medical education have earned him consistent praise from students, residents and fellows,” said Chris M. Gonzalez, MD, MBA, FACS, Regional Chief Clinic Officer of Trinity Health Illinois/Indiana Region. “His appointment marks an exciting new chapter for our program, as Dr. Hagen continues to advance our clinical capabilities and improve outcomes for patients across the region.”